Jenburkt Pharmaceuticals Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: JENBURPH BSE: 524731

₹914.60

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #107 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	435,863	146.5	13.7%	11.0%	—	72	8	30
Divi's Laboratories Limited	246,660	83.9	15.3%	62.7%	0.32%	70	4	51
Torrent Pharmaceuticals Limited	162,454	78.2	12.2%	34.6%	0.79%	56	0	31
Zydus Lifesciences Limited	115,910	33.3	17.3%	17.2%	0.09%	74	24	84
Cipla Limited	108,736	35.4	11.2%	-11.0%	0.97%	73	29	62
Laurus Labs Limited	106,969	122.5	17.1%	127.1%	—	78	24	53
Mankind Pharma Limited	103,406	47.4	11.7%	2.6%	—	68	12	86
Dr. Reddy's Laboratories Limited	102,916	154.7	10.9%	-0.9%	—	62	33	71
Jenburkt Pharmaceuticals Limited (this stock)	404	12.3	17.3%	—	2.26%	75	57	21

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹398 Cr

EV / EBITDA

8.5x

EV / Sales

2.36x

Market cap / Sales

2.39x

Earnings yield

8.13%

Quarterly Financials

Download CSV

Standalone Consolidated

↓ Negative

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 37 Cr, down 1.5% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	36	7	—	₹13.3400
March 31, 2026	45	14	—	₹24.5800
Dec. 31, 2025	43	8	—	₹13.4400
Sept. 30, 2025	46	14	10	₹23.0300
June 30, 2025	36	10	8	₹17.6600
March 31, 2025	41	12	—	₹19.3400
Dec. 31, 2024	37	10	7	₹14.7500
Sept. 30, 2024	41	13	10	₹21.7500
June 30, 2024	33	10	7	₹16.8000
March 31, 2024	39	10	8	₹17.8600
Dec. 31, 2023	36	8	5	₹12.2500
Sept. 30, 2023	38	10	7	₹16.5900
June 30, 2023	29	7	5	₹12.1700

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	37	49	45	48	38	43	38	43	34	40	37	39	30
Operating revenue	36	45	43	46	36	41	37	41	33	39	36	38	29
Other income	2	4	2	2	2	2	2	2	1	1	1	1	1
Operating expenses	29	30	36	32	27	30	28	30	23	29	28	29	22
Operating profit	6	14	7	13	9	11	9	11	9	10	7	9	7
Operating profit margin	17.0%	31.9%	17.3%	28.8%	25.2%	26.5%	23.9%	27.7%	28.6%	25.4%	20.2%	23.8%	23.9%
Depreciation	1	1	1	1	1	1	1	1	1	1	1	1	1
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0
Exceptional items, gain / (loss)	—	-4	—	—	—	—	—	—	—	—	—	—	—
Profit before tax	7	14	8	14	10	12	10	13	10	10	8	10	7
Tax	1	3	2	4	2	3	3	3	3	2	2	2	2
Net profit	—	—	—	10	8	—	7	10	7	8	5	7	5
EPS	13.34	24.58	13.44	23.03	17.66	19.34	14.75	21.75	16.80	17.86	12.25	16.59	12.17
Net profit (TTM)	—	—	—	—	—	—	31	30	28	26	24	24	24
EPS (TTM)	74.39	78.71	73.47	74.78	73.50	72.64	71.16	68.66	63.50	58.87	54.93	54.52	52.89

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	8.1%	9.5%	179^†	158^†	147^†	142^†	129^†	114^†	126^†	118^†	106^†
Operating revenue	7.3%	9.1%	169^†	152^†	142^†	137^†	124^†	109^†	123^†	115^†	103^†
Other income	—	—	10^†	7^†	5^†	5^†	5^†	4^†	3^†	3^†	3^†
Operating expenses	—	—	125^†	111^†	109^†	106^†	97^†	89^†	98^†	91^†	83^†
Operating profit	12.9%	17.1%	44^†	40^†	33^†	30^†	27^†	20^†	25^†	24^†	20^†
Operating profit margin	—	—	25.9%^†	26.6%^†	23.3%^†	22.2%^†	22.0%^†	18.2%^†	20.4%^†	20.7%^†	19.4%^†
Depreciation	—	—	3^†	3^†	2^†	2^†	2^†	2^†	1^†	2^†	2^†
Interest	—	—	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†
Exceptional items, gain / (loss)	—	—	-4^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†
Profit before tax	12.3%	16.5%	47^†	44^†	35^†	33^†	30^†	22^†	27^†	25^†	20^†
Tax	—	—	12^†	12^†	9^†	8^†	8^†	5^†	7^†	8^†	7^†
Net profit	—	—	—	—	26^†	25^†	22^†	17^†	20^†	17^†	13^†
EPS	13.6%	17.0%	78.71^†	72.64^†	58.87^†	53.69^†	48.58^†	35.97^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 19	Mar 18	Mar 17
Operating margin	25.9%^†	26.6%^†	23.3%^†	22.2%^†	22.0%^†	18.2%^†	20.4%^†	20.7%^†	19.4%^†
EBIT margin	27.8%^†	29.3%^†	25.0%^†	24.3%^†	24.4%^†	20.2%^†	22.0%^†	22.4%^†	20.2%^†
PBT margin	27.6%^†	29.0%^†	24.8%^†	24.0%^†	24.1%^†	19.8%^†	21.7%^†	22.0%^†	19.8%^†
Net margin	—	—	18.3%^†	18.0%^†	18.0%^†	15.1%^†	16.1%^†	15.0%^†	13.0%^†
Interest coverage	101.69x^†	98.02x^†	130.99x^†	90.57x^†	69.77x^†	46.70x^†	70.02x^†	62.32x^†	50.70x^†
Dividend payout	0.0%^†	0.0%^†	0.0%^†	0.0%^†	0.0%^†	0.0%^†	—	—	—
Earnings retention	100.0%^†	100.0%^†	100.0%^†	100.0%^†	100.0%^†	100.0%^†	—	—	—
Current ratio	4.11x	3.00x	—	—	—	—	—	—	—
Quick ratio	3.52x	2.53x	—	—	—	—	—	—	—
Debt to equity	0.00x	0.01x	—	—	—	—	—	—	—
Return on equity	—	—	—	—	—	—	—	—	—
Return on assets	—	—	—	—	—	—	—	—	—
Return on capital employed	23.2%^†	25.0%^†	—	—	—	—	—	—	—
Asset turnover	0.75x^†	0.77x^†	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	27	-19	-9	14	13
March 31, 2025	28	-17	-8	20	8

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	226	197	193	0	0	95	23	6	19	14
March 31, 2025	196	172	167	2	0	57	19	7	14	9

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.